Daniel Gesua Sive Salvadori sold $3.1M of ABT
EXECUTIVE VICE PRESIDENT at ABBOTT LABORATORIES. 23,771 shares at an average of $128.50, traded Jan 30, 2025, filed Jan 31, 2025.
Score components
- +15RoleOfficer
- +25Trade size$3.1M at market
- +5Share of holdings soldSold 16% of holdings
- +15Cluster4 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-25-002584, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 30, 2025 | MOption exercise Common shares without par value | +23,771 | $38.40 | $913k | 149,468 | Jan 31, 2025 |
| Jan 30, 2025 | SOpen-market sale Common shares without par value | -23,771 | $128.50 | $3.1M | 125,697 | Jan 31, 2025 |
| Jan 30, 2025 | MOption exercise Option (right to buy)derivative | -23,771 | $0.00 | $0 | 0 | Jan 31, 2025 |
Related signals
Other insiders at ABBOTT LABORATORIES and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | ABTsell ABBOTT LABORATORIES | John A. McCoy Jr. VICE PRESIDENT AND CONTROLLER | $2,958 27 shares | -0% | |
| 40Moderate | ABBOTT LABORATORIES | Daniel Gesua Sive Salvadori EVP AND GROUP PRESIDENT | $102k 885 shares | -1% | |
| 48Moderate | ABBOTT LABORATORIES | John A. McCoy Jr. VICE PRESIDENT AND CONTROLLER | $68k 585 shares | -2% | |
| 48Moderate | ABBOTT LABORATORIES | Mary K Moreland EXECUTIVE VICE PRESIDENT | $71k 613 shares | -1% | |
| 51Moderate | ABBOTT LABORATORIES | Louis H. Morrone EXECUTIVE VICE PRESIDENT | $132k 1,144 shares | -1% | |
| 39Weak | ABBOTT LABORATORIES | Eric Shroff Senior Vice President | $82k 709 shares | -2% | |
| 35Weak | ABBOTT LABORATORIES | Elizabeth C. Cushman EVP, GC AND SECRETARY | $30k 263 shares | -1% | |
| 57Moderate | ABBOTT LABORATORIES | Daniel J Starks director | $1.1M 10,000 shares | +0% | |
| 75Notable | ABBOTT LABORATORIES | Robert B Ford CHAIRMAN AND CEO | $2.0M 18,800 shares | +10% | |
| 27Weak | ABTsell ABBOTT LABORATORIES | Eric Shroff Senior Vice President | $203k 1,586 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.